Intelligence / Healthtech / De Novo Grants / Icecure Medical
Approvalsnovel device granted (FDA De Novo)3 Oct 2025
Icecure Medical
3 Oct 2025: Novel device granted (FDA De Novo) · ProSense System. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 3 Oct 2025
- Device
- ProSense System
- Specialty
- General, Plastic Surgery
- Product Code
- QXW
- Country
- Israel
- Location
- Caesarea, Israel
- Submitted
- 2022-10-19
- Reference
- DEN220077
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Icecure Medical
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in General, Plastic Surgery
De Novo Grants
30 OctVirtuoso Surgical, Inc.novel device granted (FDA De Novo) · Virtuoso Endoscopy SystemApprovals21 JulAuris Health, Inc., part of Johnson & Johnson MedTechnovel device granted (FDA De Novo) · OTTAVA Robotic Surgical SystemApprovals21 MaySpectralmd, Inc.novel device granted (FDA De Novo) · DeepView AI® SystemApprovals6 FebAmferia ABnovel device granted (FDA De Novo) · Amferia Wound DressingApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.